Stock CYTO ALTAMIRA THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Altamira Therapeutics Ltd.

Equities

CYTO

BMG0360L1349

End-of-day quote Nasdaq
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
1.45 USD -3.33% Intraday chart for Altamira Therapeutics Ltd. -11.59% -58.33%
05-01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI
04-24 Altamira Therapeutics Ltd. Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal CI

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

EBIT

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. Revisions Altamira Therapeutics Ltd.